Literature DB >> 3074314

Rates of change of common measures of impairment in senile dementia of the Alzheimer's type.

J A Yesavage, S L Poulsen, J Sheikh, E Tanke.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3074314

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN： 0048-5764


× No keyword cloud information.
  5 in total

Review 1.  Disease progression and neuroscience.

Authors:  Nick Holford
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-04-17       Impact factor: 2.745

Review 2.  Potential savings in the cost of caring for Alzheimer's disease. Treatment with rivastigmine.

Authors:  A B Hauber; A Gnanasakthy; E H Snyder; M V Bala; A Richter; J A Mauskopf
Journal:  Pharmacoeconomics       Date:  2000-04       Impact factor: 4.981

3.  Results and validation of a population pharmacodynamic model for cognitive effects in Alzheimer patients treated with tacrine.

Authors:  N H Holford; K E Peace
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

4.  Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting.

Authors:  Asa K Wallin; Carina Wattmo; Lennart Minthon
Journal:  Neuropsychiatr Dis Treat       Date:  2011-09-30       Impact factor: 2.570

5.  Depressive Symptom Profiles Predict Specific Neurodegenerative Disease Syndromes in Early Stages.

Authors:  Suzanne M Shdo; Kamalini G Ranasinghe; Virginia E Sturm; Katherine L Possin; Brianne M Bettcher; Melanie L Stephens; Jessica M Foley; Shou-Chin Christine You; Howard J Rosen; Bruce L Miller; Joel H Kramer; Katherine P Rankin
Journal:  Front Neurol       Date:  2020-05-29       Impact factor: 4.003
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.